Search research articles
Contact Us
Filters
Showing results (131-140 of 152) with videos related to
Page
of 16
Sort By:
Cancer Research
|
April 5, 2013
Cisplatin resistance associated with PARP hyperactivation
Judith Michels, Ilio Vitale, Lorenzo Galluzzi, et al.
Archives of Pathology & Laboratory Medicine
|
July 8, 2017
Immunohistochemistry of Pulmonary Biomarkers: A Perspective From Members of the Pulmonary Pathology Society
Erik Thunnissen, Timothy Craig Allen, Julien Adam, et al.
JAMA Oncology
|
September 8, 2018
Hyperprogressive Disease in Patients With Advanced Non-Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy
Roberto Ferrara, Laura Mezquita, Matthieu Texier, et al.
JCO Precision Oncology
|
September 14, 2020
Clinical Relevance of an Amplicon-Based Liquid Biopsy for Detecting <i>ALK</i> and <i>ROS1</i> Fusion and Resistance Mutations in Patients With Non-Small-Cell Lung Cancer
Laura Mezquita, Aurélie Swalduz, Cécile Jovelet, et al.
The Journal of Clinical Investigation
|
February 16, 2018
DNA repair deficiency sensitizes lung cancer cells to NAD+ biosynthesis blockade
Mehdi Touat, Tony Sourisseau, Nicolas Dorvault, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 18, 2020
High Prevalence of Somatic Oncogenic Driver Alterations in Patients With NSCLC and Li-Fraumeni Syndrome
Laura Mezquita, Maria Jové, Ernest Nadal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 6, 2022
Plasma CD27, a Surrogate of the Intratumoral CD27-CD70 Interaction, Correlates with Immunotherapy Resistance in Renal Cell Carcinoma
Nadine Benhamouda, Ikuan Sam, Nicolas Epaillard, et al.
The New England Journal of Medicine
|
March 22, 2013
ERCC1 isoform expression and DNA repair in non-small-cell lung cancer
Luc Friboulet, Ken André Olaussen, Jean-Pierre Pignon, et al.
JCO Precision Oncology
|
January 20, 2022
Comparison of Fast-Progression, Hyperprogressive Disease, and Early Deaths in Advanced Non-Small-Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or Chemotherapy
Roberto Ferrara, Laura Mezquita, Matthieu Texier, et al.
The Journal of Clinical Investigation
|
May 3, 2022
BCG therapy downregulates HLA-I on malignant cells to subvert antitumor immune responses in bladder cancer
Mathieu Rouanne, Julien Adam, Camélia Radulescu, et al.
Page
of 16
Search research articles
Search
Showing results (131-140 of 152) with videos related to
Sort By:
Page
of 16
Cancer Research
|
April 5, 2013
Cisplatin resistance associated with PARP hyperactivation
Judith Michels, Ilio Vitale, Lorenzo Galluzzi, et al.
Archives of Pathology & Laboratory Medicine
|
July 8, 2017
Immunohistochemistry of Pulmonary Biomarkers: A Perspective From Members of the Pulmonary Pathology Society
Erik Thunnissen, Timothy Craig Allen, Julien Adam, et al.
JAMA Oncology
|
September 8, 2018
Hyperprogressive Disease in Patients With Advanced Non-Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy
Roberto Ferrara, Laura Mezquita, Matthieu Texier, et al.
JCO Precision Oncology
|
September 14, 2020
Clinical Relevance of an Amplicon-Based Liquid Biopsy for Detecting <i>ALK</i> and <i>ROS1</i> Fusion and Resistance Mutations in Patients With Non-Small-Cell Lung Cancer
Laura Mezquita, Aurélie Swalduz, Cécile Jovelet, et al.
The Journal of Clinical Investigation
|
February 16, 2018
DNA repair deficiency sensitizes lung cancer cells to NAD+ biosynthesis blockade
Mehdi Touat, Tony Sourisseau, Nicolas Dorvault, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 18, 2020
High Prevalence of Somatic Oncogenic Driver Alterations in Patients With NSCLC and Li-Fraumeni Syndrome
Laura Mezquita, Maria Jové, Ernest Nadal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 6, 2022
Plasma CD27, a Surrogate of the Intratumoral CD27-CD70 Interaction, Correlates with Immunotherapy Resistance in Renal Cell Carcinoma
Nadine Benhamouda, Ikuan Sam, Nicolas Epaillard, et al.
The New England Journal of Medicine
|
March 22, 2013
ERCC1 isoform expression and DNA repair in non-small-cell lung cancer
Luc Friboulet, Ken André Olaussen, Jean-Pierre Pignon, et al.
JCO Precision Oncology
|
January 20, 2022
Comparison of Fast-Progression, Hyperprogressive Disease, and Early Deaths in Advanced Non-Small-Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or Chemotherapy
Roberto Ferrara, Laura Mezquita, Matthieu Texier, et al.
The Journal of Clinical Investigation
|
May 3, 2022
BCG therapy downregulates HLA-I on malignant cells to subvert antitumor immune responses in bladder cancer
Mathieu Rouanne, Julien Adam, Camélia Radulescu, et al.
Page
of 16